Celldex Therapeutics
CLDX
CLDX
135 hedge funds and large institutions have $223M invested in Celldex Therapeutics in 2017 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 47 increasing their positions, 38 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.14% more ownership
Funds ownership: 3.71% → 3.84% (+0.14%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
21% less call options, than puts
Call options by funds: $867K | Put options by funds: $1.1M
Holders
135
Holding in Top 10
2
Calls
$867K
Puts
$1.1M
Top Buyers
| 1 | +$15.8M | |
| 2 | +$4.32M | |
| 3 | +$2.79M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.46M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$1.17M |
Top Sellers
| 1 | -$3.75M | |
| 2 | -$2.58M | |
| 3 | -$1.13M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$922K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$811K |